| regulation of cell cycle | GO:0051726 | 393 | 1.000 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 36 | 1.000 | Mouse |
| regulation of cell cycle arrest | GO:0071156 | 36 | 1.000 | |
| mitotic cell cycle | GO:0000278 | 326 | 1.000 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 1.000 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 1.000 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 41 | 1.000 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 1.000 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 1.000 | |
| regulation of kinase activity | GO:0043549 | 314 | 1.000 | |
| cell cycle arrest | GO:0007050 | 71 | 0.999 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.999 | Human Mouse |
| cell cycle phase transition | GO:0044770 | 173 | 0.999 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.999 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 49 | 0.999 | Human |
| cell cycle g2 m phase transition | GO:0044839 | 43 | 0.999 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 78 | 0.999 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.999 | Mouse |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.999 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.999 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.999 | Human |
| ras protein signal transduction | GO:0007265 | 73 | 0.999 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.998 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.998 | |
| protein processing | GO:0016485 | 226 | 0.997 | Human |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.997 | Human Mouse |
| mitochondrion organization | GO:0007005 | 156 | 0.997 | |
| response to hormone | GO:0009725 | 175 | 0.996 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.996 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.995 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.995 | Human |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.995 | |
| response to other organism | GO:0051707 | 261 | 0.995 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.995 | |
| response to camp | GO:0051591 | 25 | 0.992 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.992 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.992 | |
| positive regulation of cyclin dependent protein serine threonine kinase activity | GO:0045737 | 15 | 0.991 | |
| positive regulation of vesicle fusion | GO:0031340 | 4 | 0.991 | |
| response to radiation | GO:0009314 | 151 | 0.990 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.990 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.990 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.989 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.989 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 60 | 0.988 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.988 | Human |
| enteroendocrine cell differentiation | GO:0035883 | 6 | 0.988 | |
| response to inorganic substance | GO:0010035 | 127 | 0.987 | Human |
| gland development | GO:0048732 | 48 | 0.986 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 107 | 0.986 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.986 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.983 | Human |
| vasculature development | GO:0001944 | 181 | 0.983 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.983 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.982 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.980 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.979 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.979 | Human Mouse |
| cellular protein catabolic process | GO:0044257 | 261 | 0.979 | |
| regulation of mitosis | GO:0007088 | 63 | 0.978 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.977 | Human |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 44 | 0.977 | |
| neutrophil clearance | GO:0097350 | 1 | 0.976 | |
| cell cycle g1 s phase transition | GO:0044843 | 80 | 0.976 | |
| mitotic g1 s transition checkpoint | GO:0044819 | 17 | 0.976 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 42 | 0.976 | |
| signal transduction in response to dna damage | GO:0042770 | 57 | 0.975 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.974 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.972 | |
| type b pancreatic cell development | GO:0003323 | 4 | 0.972 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.971 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.971 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.971 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.970 | |
| positive regulation of cell cycle process | GO:0090068 | 106 | 0.965 | |
| cell adhesion | GO:0007155 | 325 | 0.965 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.964 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.964 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.964 | |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 28 | 0.962 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.960 | Human |
| protein heterotetramerization | GO:0051290 | 3 | 0.960 | |
| organ morphogenesis | GO:0009887 | 147 | 0.955 | |
| regulation of g2 m transition of mitotic cell cycle | GO:0010389 | 20 | 0.955 | |
| positive regulation of g2 m transition of mitotic cell cycle | GO:0010971 | 8 | 0.952 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 91 | 0.952 | |
| regulation of body fluid levels | GO:0050878 | 99 | 0.952 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.950 | Mouse |
| regulation of cell differentiation | GO:0045595 | 393 | 0.949 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.948 | Mouse |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.946 | |
| glandular epithelial cell development | GO:0002068 | 5 | 0.944 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.941 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.939 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.936 | |
| secretion by cell | GO:0032940 | 226 | 0.936 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.935 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 57 | 0.935 | Mouse |
| cell aging | GO:0007569 | 52 | 0.933 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.932 | |
| regulation of protein localization | GO:0032880 | 296 | 0.932 | Mouse |
| urogenital system development | GO:0001655 | 65 | 0.930 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.928 | Human |
| positive regulation of cell cycle g2 m phase transition | GO:1902751 | 8 | 0.927 | |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 27 | 0.927 | |
| response to cytokine | GO:0034097 | 232 | 0.926 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.924 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.922 | Mouse |
| mitotic g1 dna damage checkpoint | GO:0031571 | 17 | 0.920 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.919 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.918 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.918 | |
| protein maturation | GO:0051604 | 233 | 0.915 | Human |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.913 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.912 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 2 | 0.911 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.911 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.909 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.909 | |
| peptide cross linking | GO:0018149 | 12 | 0.900 | |
| epithelial cell development | GO:0002064 | 34 | 0.900 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 19 | 0.898 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.898 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.895 | Mouse |
| secretion | GO:0046903 | 254 | 0.894 | |
| negative regulation of mitotic anaphase promoting complex activity | GO:0060564 | 4 | 0.894 | |
| negative regulation of chromosome organization | GO:2001251 | 48 | 0.892 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.891 | |
| metal ion transport | GO:0030001 | 272 | 0.886 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.883 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.882 | |
| positive regulation of fibroblast proliferation | GO:0048146 | 21 | 0.881 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.879 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 29 | 0.877 | |
| osteoclast development | GO:0036035 | 2 | 0.877 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.876 | Mouse |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.876 | |
| ion homeostasis | GO:0050801 | 230 | 0.874 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.871 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 83 | 0.871 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.870 | |
| actin filament based process | GO:0030029 | 224 | 0.867 | |
| dna replication | GO:0006260 | 116 | 0.866 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.864 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.862 | |
| jak stat cascade | GO:0007259 | 46 | 0.860 | |
| regulation of protein processing | GO:0070613 | 150 | 0.860 | |
| regulation of cell matrix adhesion | GO:0001952 | 42 | 0.858 | |
| cell growth | GO:0016049 | 160 | 0.858 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.856 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.855 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.851 | |
| protein ubiquitination | GO:0016567 | 314 | 0.850 | |
| cell matrix adhesion | GO:0007160 | 85 | 0.848 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.847 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.847 | |
| cellular senescence | GO:0090398 | 34 | 0.845 | |
| negative regulation of interleukin 8 secretion | GO:2000483 | 2 | 0.842 | |
| regulation of cell growth | GO:0001558 | 135 | 0.840 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.837 | |
| protein catabolic process | GO:0030163 | 325 | 0.837 | Human |
| peptidyl lysine modification | GO:0018205 | 144 | 0.833 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.829 | |
| positive regulation of cell cycle arrest | GO:0071158 | 23 | 0.825 | |
| cellular response to lithium ion | GO:0071285 | 2 | 0.818 | Human |
| response to growth factor | GO:0070848 | 205 | 0.817 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.815 | Human |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.811 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.809 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.808 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.808 | |
| cell division | GO:0051301 | 168 | 0.804 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.803 | |
| response to lipid | GO:0033993 | 206 | 0.799 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.798 | Human |
| negative regulation of developmental process | GO:0051093 | 247 | 0.798 | |
| response to peptide | GO:1901652 | 65 | 0.798 | |
| regulation of erythrocyte differentiation | GO:0045646 | 17 | 0.795 | |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.794 | |
| chromosome segregation | GO:0007059 | 114 | 0.791 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.790 | |
| positive regulation of transport | GO:0051050 | 336 | 0.787 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.787 | |
| cytokinesis | GO:0000910 | 96 | 0.785 | |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.785 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.780 | |
| epidermis development | GO:0008544 | 59 | 0.778 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.778 | |
| response to purine containing compound | GO:0014074 | 40 | 0.774 | |
| regulation of growth | GO:0040008 | 165 | 0.774 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.770 | |
| membrane raft assembly | GO:0001765 | 7 | 0.768 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 57 | 0.765 | Human |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.762 | |
| blood vessel development | GO:0001568 | 172 | 0.760 | |
| regulation of cell activation | GO:0050865 | 125 | 0.760 | Mouse |
| negative regulation of secretion by cell | GO:1903531 | 52 | 0.757 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.756 | |
| signal transduction by p53 class mediator | GO:0072331 | 72 | 0.754 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.751 | |
| epidermal cell differentiation | GO:0009913 | 45 | 0.747 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 156 | 0.745 | |
| negative regulation of kinase activity | GO:0033673 | 106 | 0.743 | Human Mouse |
| response to light stimulus | GO:0009416 | 87 | 0.742 | Mouse |
| biological adhesion | GO:0022610 | 331 | 0.742 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.735 | |
| neutrophil homeostasis | GO:0001780 | 3 | 0.733 | |
| regulation of locomotion | GO:0040012 | 329 | 0.727 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.726 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.725 | |
| membrane biogenesis | GO:0044091 | 13 | 0.725 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.722 | |
| calcium ion transport | GO:0006816 | 147 | 0.721 | |
| alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor clustering | GO:0097113 | 1 | 0.721 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.710 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 22 | 0.710 | |
| keratinocyte differentiation | GO:0030216 | 36 | 0.710 | |
| dna repair | GO:0006281 | 198 | 0.709 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.705 | |
| response to endoplasmic reticulum stress | GO:0034976 | 49 | 0.701 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.700 | Human |
| cellular response to glucocorticoid stimulus | GO:0071385 | 4 | 0.700 | |
| cell activation | GO:0001775 | 213 | 0.692 | Mouse |
| dna integrity checkpoint | GO:0031570 | 71 | 0.690 | |
| positive regulation of cell adhesion | GO:0045785 | 84 | 0.689 | |
| cell development | GO:0048468 | 328 | 0.686 | |
| hemopoiesis | GO:0030097 | 180 | 0.683 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.682 | |
| membrane organization | GO:0061024 | 292 | 0.682 | |
| post embryonic development | GO:0009791 | 2 | 0.681 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.681 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 5 | 0.678 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.677 | Human |
| protein tetramerization | GO:0051262 | 47 | 0.676 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.674 | |
| gtp catabolic process | GO:0006184 | 237 | 0.673 | |
| response to steroid hormone | GO:0048545 | 80 | 0.663 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.662 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.661 | Human |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 9 | 0.658 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.658 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 61 | 0.654 | |
| cellular response to ionizing radiation | GO:0071479 | 32 | 0.651 | |
| growth | GO:0040007 | 202 | 0.648 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.648 | |
| cell dedifferentiation | GO:0043697 | 1 | 0.647 | |
| cellular response to radiation | GO:0071478 | 65 | 0.645 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.641 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.640 | |
| neuron differentiation | GO:0030182 | 138 | 0.633 | |
| cytokine production | GO:0001816 | 247 | 0.631 | |
| leukocyte differentiation | GO:0002521 | 98 | 0.631 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 61 | 0.629 | |
| response to lithium ion | GO:0010226 | 2 | 0.625 | Human |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 72 | 0.622 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.622 | |
| protein deubiquitination | GO:0016579 | 79 | 0.622 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.613 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.611 | |
| gtp metabolic process | GO:0046039 | 239 | 0.610 | |
| regulation of cell migration | GO:0030334 | 289 | 0.610 | |
| negative regulation of protein secretion | GO:0050709 | 29 | 0.603 | |
| defense response | GO:0006952 | 315 | 0.599 | |
| regulation of interleukin 8 secretion | GO:2000482 | 13 | 0.596 | |
| mitotic sister chromatid separation | GO:0051306 | 18 | 0.593 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.592 | |
| response to transition metal nanoparticle | GO:1990267 | 29 | 0.589 | |
| mitotic dna integrity checkpoint | GO:0044774 | 30 | 0.587 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.585 | |
| system process | GO:0003008 | 349 | 0.584 | |
| locomotory behavior | GO:0007626 | 1 | 0.584 | |
| regulation of secretion | GO:0051046 | 194 | 0.569 | |
| regulation of cellular protein catabolic process | GO:1903362 | 96 | 0.567 | |
| myeloid cell homeostasis | GO:0002262 | 34 | 0.566 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.566 | |
| mapk cascade | GO:0000165 | 288 | 0.561 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.561 | |
| organelle fission | GO:0048285 | 149 | 0.559 | |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.558 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.557 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.557 | |
| epithelial cell migration | GO:0010631 | 119 | 0.556 | |
| regulation of calcium ion transport | GO:0051924 | 79 | 0.553 | |
| type b pancreatic cell differentiation | GO:0003309 | 5 | 0.552 | |
| circulatory system development | GO:0072359 | 262 | 0.552 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.551 | |
| hepaticobiliary system development | GO:0061008 | 10 | 0.550 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.546 | |
| response to extracellular stimulus | GO:0009991 | 85 | 0.544 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.541 | |
| regulation of microtubule polymerization | GO:0031113 | 12 | 0.536 | |
| homeostasis of number of cells | GO:0048872 | 40 | 0.536 | |
| regulation of neurotransmitter secretion | GO:0046928 | 3 | 0.534 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.532 | |
| vesicle organization | GO:0016050 | 62 | 0.528 | |
| nuclear division | GO:0000280 | 128 | 0.524 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.522 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 48 | 0.520 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.519 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.519 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.514 | |
| maintenance of location | GO:0051235 | 112 | 0.514 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.511 | |
| protein polyubiquitination | GO:0000209 | 110 | 0.509 | |
| negative regulation of cytokine secretion | GO:0050710 | 20 | 0.507 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.503 | Mouse |
| immune response | GO:0006955 | 307 | 0.503 | |
| response to drug | GO:0042493 | 81 | 0.502 | |
| single organism reproductive process | GO:0044702 | 98 | 0.501 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.498 | |
| regulation of stress activated protein kinase signaling cascade | GO:0070302 | 85 | 0.498 | |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 15 | 0.487 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.485 | |
| zymogen activation | GO:0031638 | 70 | 0.485 | Human |
| cation transport | GO:0006812 | 331 | 0.483 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.479 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.479 | |
| regulation of protein maturation | GO:1903317 | 150 | 0.467 | |
| response to uv a | GO:0070141 | 6 | 0.465 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.464 | |
| development of primary female sexual characteristics | GO:0046545 | 10 | 0.461 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 24 | 0.458 | |
| endothelial cell migration | GO:0043542 | 86 | 0.457 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.457 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.457 | |
| neutral lipid metabolic process | GO:0006638 | 27 | 0.456 | |
| negative regulation of cyclin dependent protein serine threonine kinase activity | GO:0045736 | 15 | 0.456 | Mouse |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 40 | 0.455 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 38 | 0.455 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.451 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.451 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.447 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.445 | |
| regeneration | GO:0031099 | 4 | 0.444 | |
| regulation of ion transmembrane transport | GO:0034765 | 132 | 0.442 | |
| membrane raft organization | GO:0031579 | 10 | 0.441 | |
| immune system development | GO:0002520 | 195 | 0.441 | |
| regulation of cell substrate adhesion | GO:0010810 | 68 | 0.440 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.434 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.433 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.431 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 29 | 0.430 | |
| kidney development | GO:0001822 | 53 | 0.425 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.424 | |
| negative regulation of ion transport | GO:0043271 | 39 | 0.422 | |
| negative regulation of protein modification by small protein conjugation or removal | GO:1903321 | 41 | 0.420 | |
| endocytosis | GO:0006897 | 159 | 0.420 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.420 | |
| negative regulation of protein ubiquitination | GO:0031397 | 35 | 0.419 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.417 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 37 | 0.416 | |
| asymmetric stem cell division | GO:0098722 | 1 | 0.414 | |
| regulation of cytokine secretion | GO:0050707 | 57 | 0.409 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 42 | 0.408 | |
| fibroblast proliferation | GO:0048144 | 33 | 0.407 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.401 | Human Mouse |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.397 | |
| regulation of vesicle fusion | GO:0031338 | 5 | 0.396 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.395 | |
| dna damage response signal transduction resulting in transcription | GO:0042772 | 12 | 0.391 | |
| regulation of cellular senescence | GO:2000772 | 13 | 0.391 | |
| membrane budding | GO:0006900 | 28 | 0.388 | |
| regulation of metaphase anaphase transition of cell cycle | GO:1902099 | 26 | 0.387 | |
| erythrocyte differentiation | GO:0030218 | 28 | 0.385 | |
| response to metal ion | GO:0010038 | 84 | 0.381 | Human |
| negative regulation of cellular catabolic process | GO:0031330 | 83 | 0.374 | |
| protein acetylation | GO:0006473 | 116 | 0.371 | |
| regulation of anatomical structure size | GO:0090066 | 101 | 0.370 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 76 | 0.366 | |
| regulation of protein stability | GO:0031647 | 87 | 0.365 | |
| response to glucocorticoid | GO:0051384 | 13 | 0.363 | |
| membrane assembly | GO:0071709 | 10 | 0.361 | |
| autophagic cell death | GO:0048102 | 3 | 0.358 | Human |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.358 | |
| protein heterooligomerization | GO:0051291 | 16 | 0.354 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.353 | |
| water homeostasis | GO:0030104 | 14 | 0.352 | |
| sex differentiation | GO:0007548 | 45 | 0.350 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.350 | |
| chromatin organization | GO:0006325 | 351 | 0.349 | |
| reproductive structure development | GO:0048608 | 55 | 0.348 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.348 | Mouse |
| hematopoietic stem cell differentiation | GO:0060218 | 4 | 0.347 | |
| regulation of fibroblast proliferation | GO:0048145 | 32 | 0.346 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.346 | |
| regulation of lymphocyte proliferation | GO:0050670 | 64 | 0.344 | Mouse |
| cellular response to toxic substance | GO:0097237 | 4 | 0.337 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.336 | |
| positive regulation of protein ubiquitination | GO:0031398 | 53 | 0.334 | |
| response to uv | GO:0009411 | 73 | 0.332 | Mouse |
| multicellular organismal aging | GO:0010259 | 3 | 0.330 | |
| phosphorylation of rna polymerase ii c terminal domain | GO:0070816 | 3 | 0.328 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.327 | |
| hemostasis | GO:0007599 | 76 | 0.326 | |
| reproductive system development | GO:0061458 | 56 | 0.325 | |
| regulation of microtubule based process | GO:0032886 | 74 | 0.323 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.321 | |
| organelle fusion | GO:0048284 | 36 | 0.319 | |
| peptidyl serine phosphorylation | GO:0018105 | 101 | 0.313 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.310 | |
| behavior | GO:0007610 | 112 | 0.307 | |
| regulation of ion transport | GO:0043269 | 189 | 0.306 | |
| reproductive process | GO:0022414 | 106 | 0.305 | |
| protein oligomerization | GO:0051259 | 173 | 0.305 | |
| lipid metabolic process | GO:0006629 | 381 | 0.305 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 0.304 | |
| negative regulation of mitotic metaphase anaphase transition | GO:0045841 | 17 | 0.300 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.299 | |
| cell cycle checkpoint | GO:0000075 | 117 | 0.298 | |
| regulation of protein transport | GO:0051223 | 213 | 0.298 | Mouse |
| negative regulation of dephosphorylation | GO:0035305 | 63 | 0.296 | |
| dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator | GO:0006978 | 11 | 0.295 | |
| regulation of angiogenesis | GO:0045765 | 92 | 0.295 | |
| regulation of cell division | GO:0051302 | 116 | 0.294 | |
| regulation of rho protein signal transduction | GO:0035023 | 79 | 0.292 | |
| cellular response to antibiotic | GO:0071236 | 1 | 0.292 | |
| autophagy | GO:0006914 | 88 | 0.291 | |
| response to virus | GO:0009615 | 126 | 0.289 | |
| negative regulation of transport | GO:0051051 | 176 | 0.285 | |
| positive regulation of dna metabolic process | GO:0051054 | 73 | 0.284 | |
| regulation of jnk cascade | GO:0046328 | 73 | 0.282 | |
| response to bacterium | GO:0009617 | 144 | 0.281 | |
| histone modification | GO:0016570 | 251 | 0.281 | |
| cell morphogenesis | GO:0000902 | 296 | 0.280 | |
| histone acetylation | GO:0016573 | 93 | 0.278 | |
| protein acylation | GO:0043543 | 138 | 0.278 | |
| response to corticosteroid | GO:0031960 | 15 | 0.276 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.275 | |
| positive regulation of p38mapk cascade | GO:1900745 | 8 | 0.274 | |
| rhythmic process | GO:0048511 | 31 | 0.273 | |
| dedifferentiation | GO:0043696 | 1 | 0.269 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.267 | |
| regulation of synaptic plasticity | GO:0048167 | 3 | 0.265 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.262 | |
| stress activated mapk cascade | GO:0051403 | 93 | 0.262 | |
| regulation of cell motility | GO:2000145 | 299 | 0.259 | |
| positive regulation of cell matrix adhesion | GO:0001954 | 23 | 0.258 | |
| microtubule based process | GO:0007017 | 210 | 0.258 | |
| stem cell division | GO:0017145 | 2 | 0.257 | |
| homotypic cell cell adhesion | GO:0034109 | 47 | 0.257 | |
| amine metabolic process | GO:0009308 | 44 | 0.257 | |
| negative regulation of protein kinase activity | GO:0006469 | 98 | 0.256 | Mouse |
| negative regulation of cell cycle arrest | GO:0071157 | 12 | 0.255 | |
| regulation of mitotic sister chromatid separation | GO:0010965 | 27 | 0.254 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.253 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.251 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 14 | 0.250 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.248 | |
| regulation of cell aging | GO:0090342 | 18 | 0.247 | |
| negative regulation of chromosome segregation | GO:0051985 | 18 | 0.247 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.245 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.244 | |
| monovalent inorganic cation transport | GO:0015672 | 128 | 0.243 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.242 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 10 | 0.241 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.240 | |
| regulation of cell development | GO:0060284 | 161 | 0.238 | |
| response to salt stress | GO:0009651 | 3 | 0.237 | |
| cellular response to xenobiotic stimulus | GO:0071466 | 29 | 0.237 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.237 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.234 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.233 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.233 | |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.232 | |
| negative regulation of leukocyte activation | GO:0002695 | 26 | 0.230 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.229 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.229 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.228 | |
| positive regulation of proteasomal protein catabolic process | GO:1901800 | 35 | 0.228 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.226 | |
| regulation of cell projection organization | GO:0031344 | 107 | 0.223 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.223 | |
| regulation of nuclear division | GO:0051783 | 65 | 0.220 | |
| response to oxidative stress | GO:0006979 | 121 | 0.219 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.219 | Mouse |
| lymphocyte proliferation | GO:0046651 | 70 | 0.218 | Mouse |
| postsynaptic membrane organization | GO:0001941 | 2 | 0.218 | |
| myeloid leukocyte differentiation | GO:0002573 | 60 | 0.211 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.211 | |
| establishment of protein localization to membrane | GO:0090150 | 121 | 0.211 | |
| response to estrogen | GO:0043627 | 47 | 0.211 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.210 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.206 | Mouse |
| developmental process involved in reproduction | GO:0003006 | 66 | 0.205 | |
| generation of neurons | GO:0048699 | 152 | 0.203 | |
| g1 dna damage checkpoint | GO:0044783 | 18 | 0.203 | |
| positive regulation of cell growth | GO:0030307 | 48 | 0.202 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.201 | |
| protein polymerization | GO:0051258 | 71 | 0.201 | |
| regulation of exocytosis | GO:0017157 | 46 | 0.200 | |
| aging | GO:0007568 | 66 | 0.200 | |
| neutrophil aggregation | GO:0070488 | 2 | 0.199 | |
